Cargando…
Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer
Advances in the understanding of the Hippo signaling as a key regulatory pathway of proliferation and apoptosis have provided mechanical insights for controlling organ size and tumorigenicity. Recently, much attention has been directed to the regulation of LATS1/2 (large tumor suppressor) kinases th...
Autores principales: | Kim, Youngeun, Jho, Eek-hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498137/ https://www.ncbi.nlm.nih.gov/pubmed/28502290 http://dx.doi.org/10.5483/BMBRep.2017.50.6.078 |
Ejemplares similares
-
Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling
por: Kim, Soyoung, et al.
Publicado: (2016) -
Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
por: Shao, Xuejing, et al.
Publicado: (2022) -
miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia
por: Pei, Han Zhong, et al.
Publicado: (2023) -
Regulation of the Hippo signaling pathway by ubiquitin modification
por: Kim, Youngeun, et al.
Publicado: (2018) -
Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma
por: Wu, Yue, et al.
Publicado: (2023)